Adlai Nortye Group Ltd. (ANL) Form 10-K Annual Reports
Adlai Nortye Group Ltd. (ANL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANL
CIK: 1944552
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Mazars USA LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerYingho Leung
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-10-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-109576 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | PRIMARY DOCUMENT | 0002129331-26-000006 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-104908 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-104846 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | PRIMARY DOCUMENT | 0002129331-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-09-18 | — | 144 Filing | 0002129331-26-000004 | View SEC Doc Filr Page |
| EFFECT | 2026-09-15 | — | EFFECT Filing | 9999999995-26-002965 | View SEC Doc Filr Page |
| S-8 POS | 2026-09-11 | — | REGISTRATION STATEMENT | 0001213900-26-099126 | View SEC Doc Filr Page |
| S-8 POS | 2026-09-11 | — | REGISTRATION STATEMENT | 0001213900-26-099123 | View SEC Doc Filr Page |
| POS AM | 2026-09-11 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | 0001213900-26-099117 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097850 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | PRIMARY DOCUMENT | 0002136887-26-000002 | View SEC Doc Filr Page |
| 6-K | 2026-08-26 | 2026-08-26 | CURRENT REPORT | 0001213900-26-093761 | View SEC Doc Filr Page |
| 6-K | 2026-08-19 | 2026-08-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-091426 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000929 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003685 | View SEC Doc Filr Page |
| 6-K | 2026-08-14 | 2026-08-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-089447 | View SEC Doc Filr Page |
| 3 | 2026-08-04 | 2026-03-18 | PRIMARY DOCUMENT | 0002131088-26-000001 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-084256 | View SEC Doc Filr Page |
| 424B7 | 2026-07-20 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-079449 | View SEC Doc Filr Page |
| 6-K | 2026-07-17 | 2026-07-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-078874 | View SEC Doc Filr Page |
| 3 | 2026-07-15 | 2026-03-18 | 3 Filing | 0001683168-26-005542 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2018-12-16 | PRIMARY DOCUMENT | 0002129331-26-000003 | View SEC Doc Filr Page |
| 3 | 2026-06-01 | 2026-05-28 | PRIMARY DOCUMENT | 0002136887-26-000001 | View SEC Doc Filr Page |
| 3 | 2026-05-28 | 2026-03-18 | PRIMARY DOCUMENT | 0002137419-26-000001 | View SEC Doc Filr Page |